Strong research and development programs are vital to the continued success of pharmaceutical and biotechnology companies in today's fiercely competitive markets. The costs associated with these R&D projects can be staggering. Also, the number of possible directions that a company can take it’s R&D program is growing at unprecedented rates. That is why many companies today are looking to reduce costs and limit their focus by turning to computer modeling, simulations, data mining, and other computer based methods. These strategies, however, are limited by the availability and effectiveness of the computational resources at hand.

Read more